Edition: United Kingdom  
One News Page
“Probably the fastest-access news portal in the world”
Actelion News  |<  Page 1  >> 
Share on
Share on
Post on 
Share by

Actelion, being bought by J&J, says full year profit rose 26 percent

ZURICH (Reuters) - Swiss drugmaker Actelion said on Tuesday that its full year 2016 net income rose 26 percent on accelerating sales of its newer medicines to treat deadly pulmonary arterial..

MY INVESTMENTS: Samantha Gleave on Actelion and Opap

my investments: samantha gleave on actelion and opap
Actelion Pharmaceuticals had a very attractive pipeline of new drugs in development. But OPAP, a Greek lottery and sports betting operator, was hit hard by the political crisis in the country.

Videos for actelion

News video: January a Banner Month for Global M&A Despite Uncertainty

January a Banner Month for Global M&A Despite Uncertainty 03:20

Feb.06 -- Bloomberg’s Jeff McCracken discusses global deal activity in January, President Trump’s tax proposals and mergers and acquisitions in an unpredictable market. He speaks on “Bloomberg..
Source: Bloomberg Global Business -

News video: Weekly Wrap: Dow Hits 20,000, J&J Looks for Growth

Weekly Wrap: Dow Hits 20,000, J&J Looks for Growth 02:39

We look at what the Dow's new milestone means for investors. Plus, Johnson & Johnson looks to boost its prospects, and United Technologies looks cheap.
Source: Morningstar.com -

News video: J&J Acquires Actelion for $$30 Billion

J&J Acquires Actelion for $$30 Billion 02:15

Jan.26 -- Bloomberg’s Jeffrey McCracken reports on Johnson & Johnson’s $30 billion acquisition of Actelion. He speaks on “Bloomberg Markets.”
Source: Bloomberg Global Business -

News video: Those Who Benefit From Johnson & Johnson Takeovers

Those Who Benefit From Johnson & Johnson Takeovers 00:31

Johnson & Johnson is enacting at $30 billion takeover of Europe’s biggest biotech company, Actelion. Johnson & Johnson is known for buying Swiss medical companies, and those who own stock in the..
Source: Wochit Headline News -

News video: Jim Cramer: J&J Will Do Well With Actelion

Jim Cramer: J&J Will Do Well With Actelion 00:33

Johnson & Johnson could do very well with Actelion's high blood pressure drug, but drug stocks are tenuous here, says TheStreet's Jim Cramer.
Source: The Street -


EMA panel recommends that use of Actelion's Uptravi may continue

ZURICH (Reuters) - A European Medicines Agency drug safety panel recommended on Friday that Actelion's Uptravi drug may continue to be used in line with current prescription information amid a probe..

BRIEF-J&J says upon termination of transaction agreement, under some circumstances, Actelion may be obligated to pay co a fee

* J&J - upon termination of transaction agreement, under some circumstances, Actelion may be obligated to pay co a fee - sec filing Source text - http://bit.ly/2jWFeAh Further company coverage:

Actelion, Syngenta takeovers set to shake up Swiss SMI index

ZURICH (Reuters) - The looming foreign takeovers of biotech group Actelion and agrichemicals firm Syngenta look set to trigger the biggest shake-up in the Swiss blue-chip SMI index in years just as..

J&J digs deep to claim $30bn Actelion prize

Biggest deal in group’s 130-year history is unusual in timing and concessions made

J&J boss’s long quest ends with Actelion deal

Questions asked about price paid for Swiss group and spin-off of promising new drugs

Advisers could land $100 million payday from Actelion sale

LONDON, Jan 26 (Reuters) - Advisers could pocket up to $100 million in fees from Johnson & Johnson's $30 billion acquisition of Swiss biotech firm Actelion, the largest takeover of a European...

Johnson & Johnson seals biggest European pharma deal in 13 years as it snaps up Actelion


BRIEF-J&J has two-year agreement on stake in R&D company

* J&J says on investor call it has two year agreement not to sell on the open market any equity stake in actelion research and development unit

Who bought who? The biggest deals made so far this year revealed...

who bought who? the biggest deals made so far this year revealed...
So this morning Johnson & Johnson bought Europe's biggest healthcare firm in a $31bn (£23.7bn) transaction in what was the biggest M&A deal announced so far in 2017. Which are the other big deals..
City A.M.

BRIEF-Actelion CEO hopes new R&D business to collaborate with J&J on products

* Ceo says new research company to concentrate on development, focus on research for 1-2 years

Medical couple and butcher's boy win big from Actelion sale

ZURICH (Reuters) - The 70-year-old son of a Swiss butcher is among the biggest beneficiaries of Johnson & Johnson's $30 billion takeover of Actelion, Europe's biggest biotech company.

J&J/Actelion: high pressure sale

Deal has the untidy look that can result from late concessions

BRIEF-Jupiter says J&J purchase of Actelion "very good outcome"

Jan 26 (Reuters) - * Jupiter Fund Manager Mike Buhl-nielsen: Johnson & Johnson purchase of actelion is "very good outcome", says can see "clear synergies for j&j"

You Might Like

 |<  Page 1  >> 
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+